This is a preview of subscription content, log in via an institution to check access.
Notes
This profile has been selected from R&D Insight™, a pharmaceutical intelligence database produced by Adis International Ltd.
References
Cambridge Antibody Technology, One year results forCAT-152 in glaucoma surgery, Media Release: 4 May 2000. Available from: URL: http://www.catplc.co.uk. Media release
Cambridge Antibody Technology Group, Cambridge antibody technology announces phase II clinical trial results using CAT-152 in combined cataract and glaucoma surgery: findings at three months following operation and treatment. Media Release: [3 pages], 22 Aug 2001. Available from: URL: http://www.catplc.co.uk. Media release
Cambridge Antibody Technology (CAT), CAT announces further information on CAT-152 clinical trial results, research results and orphan drug., Media Release: [4 pages], 30Apr 2001. Available from: URL: http://www.catplc.co.uk. Media release
Rights and permissions
About this article
Cite this article
Lerdelimumab. Drugs R&D 3, 106–108 (2002). https://doi.org/10.2165/00126839-200203020-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00126839-200203020-00006